Replies to post #719985 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Horse,
You are absolutely right. References have shown that there is no difference between keytruda and opdivo. Several companies already have biosimilars in phase 3 trial. Amgen even has biosimilars for both keytruda and opdivo in phase 3 trials.

I am waiting to see to which company FDA will grant platform technology designation.

https://endpts.com/amgen-readies-phiii-trial-for-first-opdivo-biosimilar-with-launch-unlikely-before-2028/
https://www.lexology.com/library/detail.aspx?g=37efda82-adde-46fa-a1af-ef53c48d6b8b